Skip to content

Opko Health OPK Investing Cash Flow

Investing Cash Flow at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
-$152M-32.2%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$4.53M+110%
HRO
HarrowHROW
-$18.2M-8,486%
Precigen logo
PrecigenPGEN
$20.97M+425%
Immunome logo
ImmunomeIMNM
-$12.02M-336%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$49M-141%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B-22.4%
P/S1.9×-0.2×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's investing cash flow?
Opko Health (OPK) reported investing cash flow of -$1.8M in Q1 2026.
How has Opko Health's investing cash flow changed year-over-year?
Opko Health's investing cash flow decreased by 104.4% year-over-year, from $40.53M to -$1.8M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.